Investing in obesity research has never been more critical and the University is delighted with the support of the MRC and the Wellcome Trust
- Leszek Borysiewicz
The Unit is based at the Wellcome Trust-MRC Institute for Metabolic Science (IMS) on the Cambridge Biomedical Campus.
It is part of a £24 million investment by the two medical research funders into obesity research on the Cambridge site.
Obesity and its metabolic consequences are major and growing threats to public health.
The aim of the MRC Metabolic Diseases Unit (MDU) is to improve understanding of the mechanisms responsible for obesity and related metabolic diseases with the eventual goal of developing interventions to prevent and treat them.
The MDU provides direct support for high-quality programmes of research that aim to improve understanding of the basic mechanisms responsible for obesity and related metabolic diseases. It also provides key core facilities to support a wide group of investigators based at the University of Cambridge Metabolic Research Laboratories (MRL) and other world-leading centres in the Cambridge area.
The new unit, the Metabolic Diseases Unit is the first MRC university unit to be developed from scratch.
Read the full story
Image: Sugar Heart
Credit: Richard Heaven
Reproduced courtesy of the University of Cambridge
________________________________________